CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 140 filers reported holding CLOVIS ONCOLOGY INC in Q1 2016. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $134,000 | -90.6% | 74,712 | -89.4% | 0.00% | -100.0% |
| Q1 2022 | $1,420,000 | +1793.3% | 703,171 | +4060.8% | 0.00% | – |
| Q3 2021 | $75,000 | -98.2% | 16,900 | -98.4% | 0.00% | -100.0% |
| Q3 2019 | $4,187,000 | +42.3% | 1,065,298 | +438.2% | 0.01% | +40.0% |
| Q2 2019 | $2,943,000 | -68.2% | 197,928 | -46.9% | 0.01% | -66.7% |
| Q1 2019 | $9,248,000 | -19.3% | 372,605 | +168.1% | 0.03% | -26.8% |
| Q3 2017 | $11,454,000 | -66.3% | 139,000 | -61.7% | 0.04% | -66.7% |
| Q2 2017 | $33,980,000 | -4.0% | 362,919 | -34.7% | 0.12% | +3.4% |
| Q1 2017 | $35,386,000 | +3613.1% | 555,773 | +2491.3% | 0.12% | +2875.0% |
| Q4 2016 | $953,000 | -9.8% | 21,448 | -29.0% | 0.00% | -20.0% |
| Q4 2015 | $1,057,000 | -63.0% | 30,200 | -2.9% | 0.01% | -66.7% |
| Q3 2015 | $2,860,000 | +39.2% | 31,100 | +1.4% | 0.02% | +7.1% |
| Q2 2013 | $2,054,000 | – | 30,663 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |